Effectiveness of a quality improvement intervention in reducing cardiovascular risk in hypertensive patients;Efectividad de una intervención de mejora de calidad en la reducción del riesgo cardiovascular en pacientes hipertensos

Revista Espanola de Cardiologia

Volumn 57, Issue 7, 2004, Pages 644-651

  García Ortiz, Luis ^a,c   Santos Rodríguez, Ignacio ^b   Sánchez Fernández, Pedro L ^b   Mora Santiago, María C ^a   Arganda Maya, José ^a   Rodríguez Corral, María T ^a  

^a Biomedical Research Institute of Salamanca IBSAL   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c NONE   (Spain)

Author keywords

Coronary disease; Hypertension; Primary care; Quality assurance

Indexed keywords

LIPID;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL STAFF; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; RISK REDUCTION; SMOKING; STAFF TRAINING; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 4344674919     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13064190     Document Type: Article

References (32)

1. Grupo de prevención cardiovascular del programa de actividades preventivas y promoción de la salud (PAPPS) de la Sociedad Española de, Medicina de Familia y Comunitaria (semFYC). Guía de prevención cardiovascular. Madrid: Sersa, 1996; p. 12-6.
2. Grupo de prevención cardiovascular del programa de actividades preventivas y promoción de la salud (PAPPS) de la Sociedad Española de Medicina de Familia y Comunitaria (semFYC). Guía de prevención cardiovascular en atención primaria. Barcelona: semFYC ed., 2003; p. 15-20.
3. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An update coronary risk profile. A stament for health professionals. Circulation 1991;83:356-62.
4. Grundy S, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999;100:1481-92.
5. Shaper AG, Pococok SJ Philips AN, Walter M. Identifying men at high risk of heart attacks: stategy for use in general practice. Br Med J 1986;293:474-9.
6. Tunstall-Pedoe H. The Dundee coronary risk-disk for management of change in risk factors. BMJ 1991;303:744-7.
7. Assmann G, Cullen P, Schulte H. The Munster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J 1998; 19(Suppl A):2-11.
8. Conroy P, Pyörala K, Fitzgerald A, Sans S, Menotti A, De Backer, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart 12003;24:987-1003.
9. De Baker G, Ambrossioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2003;10(Suppl 1):1-78.
10. Wilson P, D'Agostino R, Levy D, Belanger A, Silbershatz H, Kannel W. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
11. Grundy S. Primary prevention of coronary heart disease: integrating risk assessment with intervention. Circulation 1999;100:988-98.
12. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998; 19:1434-503.
13. Jackson R. Update New Zealand cardiovascular disease risk-benefit prediction guide. BMJ 2000;320:709-10.
14. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovas J, Cordón F, et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol 2003;56:253-61.
15. Brotons C. Mejoremos la predicción del riesgo coronario en España. Rev Esp Cardiol 2003;56:225-7.
16. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997;157:2413-46.
17. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNV 7). Hypertension 2003;42:1206-52.
18. Guidelines subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999;17:151-83.
19. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92.
20. Guidelines committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
21. Plaza I, Villar F, Mata P, Pérez F, Maiquez A, Casasnovas JA, et al. Control de la Colesterolemia en España 2000. Un instrumento para la prevención cardiovascular. Rev Esp Cardiol 2000;53:815-37.
22. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Colesterol in Adults (Adult Treatment Panel III) JAMA 2001;285:2486-97.
23. Kannel WB. Factores de riesgo en la enfermedad coronaria: experiencia del seguimiento durante tres décadas del estudio de Framingham. Hipertens Arterioscl 1989;1:77-86.
24. Mertell N, García F, Rodríguez A, Galgo A, López MD, Abad E, et al. Riesgo cardiovascular absoluto en hipertensos y su evolución con el tratamiento antihipertensivo. Hipertensión 2001;18: 72-7.
25. De la Sierra A, Ruilope LM, Coca A, Luque-Otero M, en representación del GEDEC (Grupo Español de Estudios Cardiovasculares). Relación entre el perfil de riesgo cardiovascular y la selección y utilización de los fármacos antihipertensivos. Med Clin (Barc) 2000;115:41-5.
26. Barrios V, Campuzano R, Peña G, Guzmán G, Ruilope LM. Estratificación del riesgo cardiovascular en hipertensos en atención primaria e impacto sobre el tratamiento antihipertensivo. Estudio DIORISC. Hipertensión 2002;19:114-20.
27. Lindholm LH, Ekbom T, Dash C, Eriksson M, Tibblin G, Schersten B. The impact of health care advice given in primary care on cardiovascular risk. BMJ 1995;310:1105-9.
28. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family heart Study. BMJ 1994;308: 313-20.
29. Jamtvedt G, Young JM, Kristoffersen DT, Thomson O'Brien MA, Oxman AD. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2003;3:CD000259.
30. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Hervey EL. Audit and feedback versus alternative strategies: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000;2:CD000260.
31. Freemantle N, Hervey EL, Wolf F, Grimshaw JM, Grilli R, Bero LA. Printed educational materials: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000; 2:CD000172.
32. Oxman A, Thomson M, Davis D, Haynes B. No magic bullets: systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J 1995;153:1423-31.